From April..... What I am liking most is the strong EBITDA trend. FY17 Q1. $2.2m Q2. $2.5m Q3. $3m Q4. $3.3m (based on trend and record mentioned) FY17 EBITDA = $11m Still under 4x? at 19c
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025